DoD SBIR/STTR for Academic Researchers: Topics, Eligibility and How to Apply

Why DoD SBIR Is Back in the Conversation

The SBIR and STTR programs lapsed on September 30, 2025, and for months nobody could issue new solicitations. Third-party trackers report that reauthorization was signed on April 13, 2026, extending the programs through 2031. The Department of War, which is the name now used on its own press materials, says it issued multiple solicitations right after the restart, including more than 90 topics. Other trackers count 115 topics in the first release. I can't reconcile those numbers from public snippets, and the exact opening date varies by source too (April 13 and April 14 both appear).

The practical takeaway is simpler than the bookkeeping. After a lapse, agencies tend to push a lot of topics out quickly, and a pent-up applicant pool follows. That usually means the first releases are crowded. Later releases may be a better fit for a lab that's starting from zero.

How DoD SBIR Topics Actually Get Released

This is the biggest culture shock for NIH people. NIH publishes a parent SBIR/STTR announcement and you write to your own idea. DoD works the other way around: components such as the Army, Navy, Air Force, Space Force, DARPA, DTRA, and MDA write specific topics, each describing a problem, and you propose a solution to that problem. Topics are published through the Defense SBIR/STTR Innovation Portal (DSIP). Sources I found list different web addresses for the portal, so go through the official defensesbirsttr.mil site rather than a link from a blog.

Releases appear to come in rolling windows. One tracker describes a Release 2 with 42 topics and a June 24 close, and another describes a Release 3 closing July 22. Reported cadence is roughly monthly through the fiscal year, though I'd treat any calendar from an aggregator as provisional. The reliable pattern is that there's a pre-release period, when topics are visible and you can contact the topic author with questions, followed by the open period, when you can't. That pre-release conversation is where an academic collaborator can learn whether the topic is really written around an incumbent contractor.

Eligibility: The Company Applies, Not the University

Universities can't be the SBIR applicant. The applicant must be a U.S. small business concern, generally defined as 500 or fewer employees including affiliates. If your lab has a startup, or you plan to form one, that entity is the awardee. The PI usually has to be primarily employed by the company at the time of award for SBIR, which is a real constraint if you hold a full-time faculty appointment. The details differ by agency, and I haven't found a clean statement of the DoD version in public snippets, so read the solicitation's eligibility section line by line.

Ownership matters too. Companies majority-owned by venture capital, hedge funds, or private equity can face different rules for SBIR versus STTR. If you have outside investors, have someone read 13 CFR 121.702 and the SBA SBIR/STTR Policy Directive before you invest weeks in a proposal. One Army STTR topic I saw also mentioned a joint venture certification that other components didn't include, so the paperwork isn't necessarily uniform across the department.

DoD SBIR/STTR and the University Partner

STTR is the DoD SBIR/STTR flavor most relevant to a faculty member. It requires a formal cooperative research arrangement between the small business and a research institution, with a minimum share of the work performed by the institution. At NIH the research-institution minimum has long been 30 percent for STTR, with the business doing at least 40 percent. I couldn't confirm the DoD percentages for the 2026 solicitations from the snippets I read, so confirm them in the BAA instructions instead of assuming they match NIH.

Two things to settle early with your technology transfer office: intellectual property rights between the company and the university, and whether your institution's conflict-of-interest policy allows you to hold equity in the company receiving your university's subaward. Both are slow, and the DoD clock doesn't care. Also note that defense awards can carry data-rights, export-control, and cybersecurity obligations that NIH awards rarely do. If your lab uses foreign nationals on the project, ask your export-control office before the topic window opens, not after.

Award Sizes and Timelines

Reported DoD Phase I amounts vary a lot by source and component. Aggregators commonly cite about $250,000, with a wider range of roughly $50,000 to $275,000 mentioned elsewhere. One source describes an April 2026 threshold of $323,090 for Phase I, above which an agency needs SBA approval. An Army STTR topic listed a $300,000 ceiling with a performance period of one to six months. Phase II figures reported run around $1.7 to $1.8 million, and Direct-to-Phase II up to about $2 million.

Don't budget from any of those numbers. Each topic states its own ceiling and period of performance, and these differ between components. A six-month Phase I is a very different scientific proposition from the 12-month NIH Phase I most biomedical labs picture, so scope your feasibility question to fit the shorter window.

DoD vs NIH Small Business Funding

The honest framing is that NIH funds your idea and DoD funds its own need. NIH reviewers score Significance, Investigator, Innovation, Approach, and Environment against a study section. DoD evaluators tend to weigh technical merit, the plausibility of a transition path to a program or contractor, and commercialization together, and a topic author or program office often has a strong say. If your work is a disease mechanism, NIH remains the natural home. If it's a field-deployable diagnostic, a wearable sensor, battlefield trauma care, biosecurity, or a computational tool that works under degraded conditions, DoD is a realistic second door.

Applying to both for different aspects of a technology is common and generally permitted, but disclosing overlap honestly is not optional. Our NIH SBIR/STTR Phase I guide covers the NIH side, and the DOE and NSF posts linked below show how other agencies handle the same company-plus-university structure.

A Practical First Month

In week one, register in DSIP, create the company-side identifiers SBIR applications require, and read the current topic list with a single question in mind: which two or three topics describe a problem my lab has already made measurable progress on? Ignore the rest. Week two, email the topic authors during any pre-release window and ask what a competitive solution looks like and whether any incumbent solution already exists. Keep the message short and don't pitch.

In weeks three and four, sort out the company structure, the university agreement, and your own employment status. If any of the three looks unresolvable inside two months, wait for a later release rather than submitting a rushed proposal. With rolling windows, missing one isn't the end of the line, and a clean submission in a later cycle beats a compromised one now. I'm honestly uncertain how crowded each release will be, so I wouldn't build a plan on guessed odds.

Frequently Asked Questions